Medistem Develops New Adult Stem Cell Therapy for Saving Limbs
The biotech company Medistem demonstrates the therapeutic value of allogeneic endometrial regenerative cells in the treatment of critical limb ischemia.
August 19, 2008
The biotech company Medistem demonstrates the therapeutic value of allogeneic endometrial regenerative cells in the treatment of critical limb ischemia.
The Harvard Stem Cell Institute announces the creation of 20 new, non-stem cell, cell lines which target specific diseases.
The biotech company Pluristem Therapeutics has developed an adult stem cell product for the prevention of clinical symptoms of multiple sclerosis.
Adult stem cells derived from bone marrow are used to treat restenosis in an animal model.
Adult stem cells taken from the dental pulp of teeth have been shown to promote the proliferation and differentiation of endogenous neural cells in an animal model.
Nine people with broken legs are healed with their own stem cells.